Composite Inflammatory Indices for the Differentiation of Tuberculosis, Sarcoidosis, and Reactive Lymphadenopathy in Patients Undergoing EBUS-TBNA

Buğra Kerget; Sırma Merve Çetin; Mustafa Buğra Coşkuner

doi:10.36141/svdld.2026.18673

Authors

Buğra Kerget {"en_US":"Ataturk University"}
Sırma Merve Çetin Aksaray University
Mustafa Buğra Coşkuner Aksaray University

Keywords:

tuberculosis, : Sarcoidosis, endobronchial ultrasound

Abstract

Background: Differentiating mediastinal lymphadenopathy (LAP) due to tuberculosis, sarcoidosis, and reactive causes remains challenging because of overlapping clinical and radiological features. This study aimed to evaluate the diagnostic value of the systemic inflammation composite index (SICI), the platelet inflammation composite index (PICI), and other hematological indices for this differentiation.

Methods: This retrospective study included 223 patients who underwent endobronchial ultrasound–guided transbronchial needle aspiration (EBUS-TBNA) for mediastinal LAP between 2020 and 2025. Pre-procedural laboratory data were used to calculate the platelet-to-lymphocyte ratio (PLR), neutrophil-to-lymphocyte ratio (NLR), systemic immune-inflammation index (SII), and the newly defined SICI and PICI.

Results: PLR, NLR, SII, SICI, and PICI levels were highest in the tuberculosis group and were significantly higher in patients with granulomatous LAP than in those with reactive LAP (p < 0.001 for all). In differentiating tuberculosis from sarcoidosis, a SICI cut-off value of 10966.6 yielded a sensitivity of 83% and a specificity of 63%, while a PICI cut-off value of 2.2 yielded a sensitivity of 85% and a specificity of 60%. For distinguishing granulomatous from reactive LAP, the optimal cut-off values were 77.4 for PLR (sensitivity 98%, specificity 67%), 2721.5 for SICI (sensitivity 89%, specificity 63%), and 0.69 for PICI (sensitivity 87%, specificity 61%).

Conclusion: SICI and PICI, introduced for the first time in the literature, are readily available composite indices that may aid in differentiating tuberculosis-, sarcoidosis-, and reactive LAP–related mediastinal LAP.

References

1. Scano V, Fois AG, Manca A, Balata F, Zinellu A, Chessa C, et al. Role of EBUS-TBNA in non-neoplastic mediastinal lymphadenopathy: review of literature. Diagnostics. 2022;12(2):512.

2. Ayub II, Mohan A, Madan K, Hadda V, Jain D, Khilnani G, et al. Identification of specific EBUS sonographic characteristics for predicting benign mediastinal lymph nodes. The clinical respiratory journal. 2018;12(2):681-90.

3. Matache SR, Afetelor AA, Voinea AM, Cosoveanu GC, Dumitru S-M, Alexe M, et al. Balancing accuracy, safety, and cost in mediastinal diagnostics: a systematic review of EBUS and mediastinoscopy in NSCLC. Healthcare: MDPI; 2025. p. 1924.

4. Boni FG, Hamdi I, Koundi LM, Shrestha K, Xie J. Cytokine storm in tuberculosis and IL-6 involvement. Infection, Genetics and Evolution. 2022;97:105166.

5. Gunawan LS, Livrança EJO, Ismawatie E. Correlation Between Leukocyte Count and Erythrocyte Sedimentation Rate in Pulmonary Tuberculosis Patients at Suai Referral Hospital, Timor Leste. Journal of Indonesian Medical Laboratory and Science (JoIMedLabS). 2025;6(2):147-56.

6. Batool Y, Pervaiz G, Arooj A, Fatima S. Hematological manifestations in patients newly diagnosed with pulmonary tuberculosis. Pakistan Journal of Medical Sciences. 2022;38(7):1968.

7. Rossides M, Darlington P, Kullberg S, Arkema EV. Sarcoidosis: Epidemiology and clinical insights. Journal of internal medicine. 2023;293(6):668-80.

8. Kerget B, Afşin DE, Aksakal A. The role of systemic immune-inflammation index (SII) in the differential diagnosis of granulomatous and reactive LAP diagnosed by endobronchial ultrasonography. Sarcoidosis, Vasculitis, and Diffuse Lung Diseases. 2023;40(3):e2023038.

9. Alamdari MG, Kalami N, Shojaan H, Aminizadeh S, Ghaedi A, Bazrgar A, et al. Systematic review of the diagnostic role of neutrophil to lymphocyte ratio in sarcoidosis. Sarcoidosis, Vasculitis, and Diffuse Lung Diseases. 2023;40(1):e2023008.

10. Berns SA, Isakova JA, Pekhtereva PI. Therapeutic potential of interferon-gamma in tuberculosis. ADMET and DMPK. 2022;10(1):63-73.

11. Weeratunga P, Moller DR, Ho LP. Immune mechanisms of granuloma formation in sarcoidosis and tuberculosis. J Clin Invest. 2024;134(1). doi: 10.1172/jci175264.

12. Faraz M, Rosado FGN. Reactive Lymphadenopathies. Clin Lab Med. 2021;41(3):433-51. doi: 10.1016/j.cll.2021.04.001.

13. Iliaz S, Iliaz R, Ortakoylu G, Bahadir A, Bagci BA, Caglar E. Value of neutrophil/lymphocyte ratio in the differential diagnosis of sarcoidosis and tuberculosis. Ann Thorac Med. 2014;9(4):232-5. doi: 10.4103/1817-1737.140135.

14. Kerget B, Afşin DE, Aksakal A. The role of systemic immune-inflammation index (SII) in the differential diagnosis of granulomatous and reactive LAP diagnosed by endobronchial ultrasonography. Sarcoidosis Vasc Diffuse Lung Dis. 2023;40(3):e2023038. doi: 10.36141/svdld.v40i3.14743.

15. Yalnız E, Karadeniz G, Üçsular FD, Erbay Polat G, Şahin GV. Predictive value of platelet-to-lymphocyte ratio in patients with sarcoidosis. Biomarkers in Medicine. 2019;13(3):197-204.

16. Günlüoğlu G, Şimşek Veske N, Akbaba Bağcı B, Aktepe Sezgin EN, Pamir P, Bolat E, et al. Relationship between disease severity and blood cells ratios in tuberculosis. Haydarpaşa Numune Medıcal Journal.66(1):0-.

17. Kerget B, Aydin Y, Özmen S, Afşin DE, Yılmazel Uçar E, Sağlam L. Can hematological parameters guide the differentiation between sarcoidosis and tuberculous lymphadenitis? Eurasian Journal of Pulmonology. 2021;23(1):19.